J H Kempen

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome
    J H Kempen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Arch Ophthalmol 119:33-40. 2001
  2. ncbi Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome
    John H Kempen
    Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    Arch Ophthalmol 121:466-76. 2003
  3. ncbi Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis
    John H Kempen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, 550 North Broadway, Suite 700, Baltimore, MD 21205, USA
    Am J Ophthalmol 139:1028-34. 2005
  4. ncbi The prevalence of diabetic retinopathy among adults in the United States
    John H Kempen
    Department of Ophthalmology, Johns Hopkins School of Medicine, 550 N Broadway, Suite 700, Baltimore, MD 21205, USA
    Arch Ophthalmol 122:552-63. 2004
  5. ncbi Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome
    John H Kempen
    Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 37:1365-73. 2003
  6. ncbi Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS
    J H Kempen
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Pharmacoeconomics 19:1199-208. 2001
  7. ncbi The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy
    John H Kempen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 110:987-95. 2003
  8. ncbi Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes
    Douglas A Jabs
    Department of Ophthalmology, The Mount Sinai School of Medicine, New York, New York, USA
    Ophthalmology 117:2152-61.e1-2. 2010
  9. ncbi Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis
    John H Kempen
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 113:684-94. 2006
  10. ncbi Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS
    Jennifer E Thorne
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:591-8. 2007

Detail Information

Publications44

  1. ncbi Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome
    J H Kempen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Arch Ophthalmol 119:33-40. 2001
    ....
  2. ncbi Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome
    John H Kempen
    Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    Arch Ophthalmol 121:466-76. 2003
    ..To characterize the effect of cytomegalovirus (CMV) retinitis and its treatment on visual acuity in patients with the acquired immunodeficiency syndrome...
  3. ncbi Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis
    John H Kempen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, 550 North Broadway, Suite 700, Baltimore, MD 21205, USA
    Am J Ophthalmol 139:1028-34. 2005
    ..To evaluate the risk and risk factors for developing cytomegalovirus (CMV) retinitis in previously uninvolved second eyes among patients with unilateral CMV retinitis...
  4. ncbi The prevalence of diabetic retinopathy among adults in the United States
    John H Kempen
    Department of Ophthalmology, Johns Hopkins School of Medicine, 550 N Broadway, Suite 700, Baltimore, MD 21205, USA
    Arch Ophthalmol 122:552-63. 2004
    ..To determine the prevalence of diabetic retinopathy among adults 40 years and older in the United States...
  5. ncbi Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome
    John H Kempen
    Department of Ophthalmology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 37:1365-73. 2003
    ....
  6. ncbi Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS
    J H Kempen
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Pharmacoeconomics 19:1199-208. 2001
    ....
  7. ncbi The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy
    John H Kempen
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 110:987-95. 2003
    ..Newly diagnosed CMV retinitis also is associated with lower general health-related QOL in most domains and with lower health utility...
  8. ncbi Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes
    Douglas A Jabs
    Department of Ophthalmology, The Mount Sinai School of Medicine, New York, New York, USA
    Ophthalmology 117:2152-61.e1-2. 2010
    ..To describe the 5-year outcomes of patients with cytomegalovirus (CMV) retinitis and AIDS in the era of highly active antiretroviral therapy (HAART)...
  9. ncbi Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis
    John H Kempen
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 113:684-94. 2006
    ..To evaluate the prevalence of and risk factors for immune recovery uveitis (IRU) in eyes of patients with AIDS and cytomegalovirus (CMV) retinitis...
  10. ncbi Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS
    Jennifer E Thorne
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:591-8. 2007
    ....
  11. ncbi Methotrexate for ocular inflammatory diseases
    Sapna Gangaputra
    Department of Ophthalmology, The Fundus Photograph Reading Center, University of Wisconsin, Madison, Wisconsin, USA
    Ophthalmology 116:2188-98.e1. 2009
    ..To evaluate the outcome of treatment with methotrexate for noninfectious ocular inflammation...
  12. ncbi The prevalence of refractive errors among adults in the United States, Western Europe, and Australia
    John H Kempen
    Johns Hopkins University School of Medicine, 550 N. Broadway, Suite 700, Baltimore, MD 21205, USA
    Arch Ophthalmol 122:495-505. 2004
    ..Projected prevalence rates in 2020 were similar. CONCLUSIONS: Refractive errors affect approximately one third of persons 40 years or older in the United States and Western Europe, and one fifth of Australians in this age group...
  13. ncbi Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis
    Angelo P Tanna
    Department of Ophthalmology, Northwestern University Medical School, Chicago, Illinois, USA
    Am J Ophthalmol 136:1009-15. 2003
    ..To determine the incidence of and risk factors for cataract and to describe the visual outcomes of cataract surgery in eyes with cytomegalovirus-related retinal detachments repaired with silicone oil...
  14. ncbi Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy
    E Daniel
    Schieffelin Leprosy Research and Training Centre, Vellore, India
    Br J Ophthalmol 90:568-73. 2006
    ..To evaluate the incidence of and risk factors for ocular complications in multibacillary (MB) leprosy patients during their 2 year, fixed duration, multidrug therapy (MDT)...
  15. ncbi Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy
    E Daniel
    Schieffelin Leprosy Research and Training Centre, Vellore, Tamil Nadu, India
    Br J Ophthalmol 90:949-54. 2006
    ..To evaluate the incidence of and risk factors for ocular complications in multibacillary (MB) leprosy patients following completion of 2 year, fixed duration, multidrug therapy (MDT)...
  16. ncbi Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Jennifer E Thorne
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 113:1441-5. 2006
    ..To quantitate the frequencies of the common causes of visual acuity loss for patients with AIDS and cytomegalovirus (CMV) retinitis in the era of highly active antiretroviral therapy (HAART)...
  17. ncbi Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Jennifer E Thorne
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 113:1432-40. 2006
    ..To describe the incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus (CMV) retinitis in the era of highly active antiretroviral therapy (HAART)...
  18. ncbi Vogt-Koyanagi-Harada disease: clinical outcomes
    Irina Bykhovskaya
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Ophthalmol 140:674-8. 2005
    ..08; P = .04, respectively). CONCLUSION: VKH disease may result in substantial visual impairment. The use of oral corticosteroid or immunosuppressive drug therapy may reduce the risk of vision loss during the follow-up period...
  19. ncbi Recurrent nodular scleritis preceding an adult TINU syndrome
    Ebenezer Daniel
    Division of Ocular Immunology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Ocul Immunol Inflamm 14:239-40. 2006
    ..To describe the occurrence of nodular scleritis in a patient developing tubulointerstitial nephritis and uveitis (TINU) syndrome...
  20. ncbi HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial
    Douglas A Jabs
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    AIDS 16:877-87. 2002
    ..Anti-CMV therapy provided a transient reduction in CMV viremia in newly diagnosed but not relapsed patients with CMV retinitis. Adjuvant therapy with MSL-109 was ineffective in clearing CMV-DNA and CMV antigen from the plasma...
  21. ncbi Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment
    Douglas A Jabs
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:787-93. 2007
    ..To report the clinical features on eye examination of patients with AIDS in the era of highly active antiretroviral therapy (HAART)...
  22. ncbi Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment
    Douglas A Jabs
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 114:780-6. 2007
    ..To report the prevalence of ocular complications of AIDS in the era of highly active antiretroviral therapy (HAART)...
  23. ncbi Azathioprine for ocular inflammatory diseases
    Sirichai Pasadhika
    Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA
    Am J Ophthalmol 148:500-509.e2. 2009
    ..To evaluate treatment outcomes of azathioprine for noninfectious ocular inflammatory diseases...
  24. ncbi The impact of anemia on energy and physical functioning in individuals with AIDS
    Richard D Semba
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
    Arch Intern Med 165:2229-36. 2005
    ..To our knowledge, the relationship between changes in hemoglobin level and energy and physical functioning in the anemic and "normal" ranges of hemoglobin among individuals with AIDS has not been well characterized...
  25. ncbi Hypopyon in patients with uveitis
    Ali A Zaidi
    Department of Ophthalmology, The University of Pennsylvania, The Ocular Inflammation Service and Center for Preventive Ophthalmology and Biostatistics, Philadelphia, Pennsylvania, USA
    Ophthalmology 117:366-72. 2010
    ..To evaluate the risk of and risk factors for hypopyon among patients with uveitis and to evaluate the risk of visual changes and complications after hypopyon...
  26. ncbi The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics
    John H Kempen
    Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania, 3535 Market Street, Suite 700, Philadelphia, PA 19104, USA
    Am J Ophthalmol 149:550-561.e10. 2010
    ..To describe the design and methods of the Multicenter Uveitis Steroid Treatment (MUST) trial and the baseline characteristics of enrolled patients...
  27. ncbi Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection
    Irene C Kuo
    Department of Ophthalmology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA
    Am J Ophthalmol 138:338-46. 2004
    ..To describe the characteristics and outcomes of patients with cytomegalovirus (CMV) retinitis in the absence of human immunodeficiency virus (HIV) infection...
  28. ncbi Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy
    Douglas A Jabs
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 112:771-9. 2005
    ..To evaluate risk factors for mortality among patients with AIDS in the era of highly active antiretroviral therapy (HAART), particularly the effect of cytomegalovirus (CMV)...
  29. ncbi Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis
    Douglas A Jabs
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Ophthalmol 135:26-34. 2003
    ..To evaluate whether cytomegalovirus resistant to ganciclovir, detected in either the blood or urine, correlates with adverse ocular outcomes...
  30. ncbi Birdshot retinochoroidopathy: ocular complications and visual impairment
    Jennifer E Thorne
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21250, USA
    Am J Ophthalmol 140:45-51. 2005
    ..To describe the incidence of vision loss and of ocular complications attributable to birdshot retinochoroidopathy and to describe the association between therapy and the incidence thereof...
  31. ncbi Mycophenolate mofetil therapy for inflammatory eye disease
    Jennifer E Thorne
    Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Ophthalmology 112:1472-7. 2005
    ..To evaluate treatment outcomes with mycophenolate mofetil in patients with inflammatory eye disease...
  32. ncbi Retinal vascular occlusion in patients infected with human immunodeficiency virus
    James P Dunn
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Retina 25:759-66. 2005
    ..To describe the clinical features of retinal vascular occlusions (macrovasculopathy) and the proportion of affected patients with human immunodeficiency virus (HIV) infection...
  33. ncbi Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Douglas A Jabs
    Wilmer Eye Institute, 550 North Broadway, Suite 700, Baltimore, Maryland 21205, USA
    Am J Ophthalmol 133:48-61. 2002
    ..To describe the characteristics of patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART)...
  34. ncbi Cyclosporine for ocular inflammatory diseases
    R Oktay Kaçmaz
    Department of Ophthalmology, The Mount Sinai School of Medicine, New York, New York, USA
    Ophthalmology 117:576-84. 2010
    ..To evaluate the clinical outcomes of cyclosporine treatment for noninfectious ocular inflammation...
  35. ncbi Disparities in access to medical care for individuals with vision impairment
    Christine Spencer
    School of Public Affairs, University of Baltimore, Baltimore, MD 21202, USA
    Ophthalmic Epidemiol 16:281-8. 2009
    ..We investigated the relationship between blindness and vision impairment and access to medical care...
  36. ncbi Medical management of human immunodeficiency virus infection
    John H Kempen
    Department of Ophthalmology, the Department of Biostatistics and Epidemiology and the Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Indian J Ophthalmol 56:385-90. 2008
    ..Research is needed to determine the optimal approach for managing cytomegalovirus retinitis in resource-constrained settings...
  37. ncbi Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis
    John H Kempen
    Center for Preventive Ophthalmologyand Biostatistics, Department of Ophthalmology, University of Pennsylvania, 3535 Market Street, Suite 700, Philadelphia, PA 19104, USA
    Am J Ophthalmol 146:813-8.e1. 2008
    ..To evaluate the reproducibility of new criteria for grading the site and activity of intraocular inflammation...
  38. ncbi Economic impact of visual impairment and blindness in the United States
    Kevin D Frick
    Department of Health Policy and Management, Health Services Research and Development Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205 1901, USA
    Arch Ophthalmol 125:544-50. 2007
    ..To assess the economic impact of excess medical and informal care and the health utility loss associated with visual impairment and blindness in adults aged 40 years and older in the United States...
  39. ncbi Methodologic rigor of clinical trials on surgical management of eyes with coexisting cataract and glaucoma
    Henry D Jampel
    Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland 21287-9205, USA
    Ophthalmology 109:1892-901. 2002
    ....
  40. ncbi Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review
    Henry D Jampel
    Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, USA
    Ophthalmology 109:2215-24; quiz 2225, 2231. 2002
    ....
  41. ncbi Surgical strategies for coexisting glaucoma and cataract: an evidence-based update
    David S Friedman
    Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland 21287, USA
    Ophthalmology 109:1902-13. 2002
    ..To assess short- and long-term control of intraocular pressure (IOP) with different surgical treatment strategies for coexisting cataract and glaucoma...
  42. ncbi Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
    John H Kempen
    Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Ophthalmic Epidemiol 15:47-55. 2008
    ....
  43. ncbi The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States
    Monique S Roy
    Institute of Ophthalmology and Visual Science, the University of Medicine and Dentistry New Jersey Medical School, 90 Bergen Street, Room 6164, Newark, NJ 07101 1709, USA
    Arch Ophthalmol 122:546-51. 2004
    ..To estimate the US prevalence of diabetic retinopathy (DR) among persons with type 1 diabetes mellitus (DM)...
  44. ncbi Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression
    Larry D Hubbard
    Department of Ophthalmology and Visual Sciences, The University of Wisconsin Medical School, Madison Wisconsin 53711 1068, USA
    Am J Ophthalmol 137:426-34. 2004
    ..To compare grading of cytomegalovirus retinitis progression by two different fundus photograph reading centers (FPRCs)...